Search results for "From ACP Internist Weekly"
SGLT-2 inhibitors not associated with increased risk for severe UTIs
An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.
https://diabetes.acponline.org/archives/2019/08/09/7.htm
9 Aug 2019
Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds
More care by nurse practitioners (NPs) and physician assistants (PAs) may be a way to expand primary care access while maintaining quality standards.
https://diabetes.acponline.org/archives/2018/12/14/10.htm
14 Dec 2018
GLP-1 receptor agonists associated with thyroid cancer
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://diabetes.acponline.org/archives/2022/12/09/6.htm
9 Dec 2022
Newer, older insulin formulations may offer similar glucose-lowering effects
The findings may help inform decisions about insulin therapy for patients with type 2 diabetes, for example, when minimizing weight gain or nocturnal hypoglycemia is a priority.
https://diabetes.acponline.org/archives/2018/07/13/8.htm
13 Jul 2018
USPSTF lowers age for starting diabetes screening from 40 to 35 years
Primary care clinicians should screen all overweight or obese adults ages 35 to 70 years for diabetes and prediabetes and should offer interventions for those with either condition, the U.S. Preventive Services Task Force (USPSTF) recently recommended.
https://diabetes.acponline.org/archives/2021/09/10/6.htm
10 Sep 2021
Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients
Even near-normal glucose levels on the last day of hospitalization were associated with increased risk for readmission and postdischarge mortality, and these risks increased as patients' glucose levels decreased.
https://diabetes.acponline.org/archives/2019/05/10/12.htm
10 May 2019
HbA1c levels may overestimate mean glucose in black type 1 diabetes patients, study finds
Editorialists cautioned that the study does not suggest that HbA1c has limited utility in black patients, adding that there is a need to better understand the subgroups that may be vulnerable to discordant HbA1c and glucose measures.
https://diabetes.acponline.org/archives/2017/07/14/6.htm
14 Jul 2017
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://diabetes.acponline.org/archives/2018/12/14/9.htm
14 Dec 2018
Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find
A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://diabetes.acponline.org/archives/2022/10/14/8.htm
14 Oct 2022
Paternal metformin use associated with major birth defects
A prospective registry-based study in Denmark found that offspring of men who filled one or more prescriptions for metformin during the three months of developing fertilizing sperm were more likely to have a birth defect, while insulin and sulfonylureas were not associated with increased risk.
https://diabetes.acponline.org/archives/2022/04/08/6.htm
8 Apr 2022